Hla-Dr/dq Transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential.

Author： Geluk A.  

Publisher： Springer Publishing Company

ISSN： 0921-299X

Source： Biotherapy, Vol.10, Iss.3, 1998-01, pp. : 191-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insights into T-Cell Development from Studies Using Transgenic and Knockout Mice

By Basson M.A.   Zamoyska R.  

Molecular Biotechnology, Vol. 18, Iss. 1, 2001-05 ,pp. : 11-23

Humana Press, Inc

Access to resources Recommend Favorite

Expression of functional human-cytosolic Cu/Zn superoxide dismutase in transgenic tobacco

By Park D.H.  

Biotechnology Letters, Vol. 24, Iss. 9, 2002-05 ,pp. : 681-686

Springer Publishing Company

Access to resources Recommend Favorite

Expression of foreign proteins in a Vibrio cholerae vaccine strain using the stationary phase hemagglutinin/protease promoter

By Hazra Anupam   Silva Anisia   Benitez Jorge  

Biotechnology Letters, Vol. 29, Iss. 7, 2007-07 ,pp. : 1093-1097

Springer Publishing Company

Access to resources Recommend Favorite

Biochemical Determination of Natural Tumor-Associated T-Cell Epitopes

By Demine Rodion   Sherev Tumenjargal   Walden Peter  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 71-78

Humana Press, Inc

Access to resources Recommend Favorite

Cell/adsorbent interactions in expanded bed adsorption of proteins

By Feuser J.  

Bioseparation, Vol. 8, Iss. 1-5, 1999-01 ,pp. : 99-109

Springer Publishing Company

Access to resources Recommend Favorite